The Philippines offers a strong track record in the conduct of infectious diseases, oncology, metabolic disorders, respiratory and cardiovascular trials.
George Clinical’s Philippines office is based in the capital city, Manila and compliments the organization’s list of global locations. Currently, the Philippines has a population of 104 million making it a rich source of patients with a high probability of recruiting treatment-native population.
Key advantages of conducting clinical trials with George Clinical in the Philippines include its high literacy rate with people fluent in the English language; wide network of hospitals and medical centers covering over 17 regions; commonly lower cost of conducting clinical trials in comparison to other Asian countries; and most physicians in the Philippines have received US-based training and experience.
Historically, the Philippines has a particularly strong track record in the conduct of infectious diseases, oncology, metabolic disorders, respiratory and cardiovascular trials. George Clinical has an extensive track record in chronic disease trials that correlates directly with the most prevalent indications in the country.
• Acute respiratory infection
• Acute lower respiratory tract infection and pneumonia
• Urinary tract infection
• Acute watery diarrhea
• Respiratory tuberculosis
• Other forms of tuberculosis
|Hospital Records Language||English|
|Electronic Hospital Records||English|
|In-country services||Project Managment
|GDP – per capita (US $)||2891.36|
|Health Expenditures||3.2% of its GDP|